LINCOLN Financial Statements

Lincoln Pharmaceuticals Key Financial Ratios

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 9.75 7.18 0.10 (10)
Op profit growth 33 25.30 11.80 15.40
EBIT growth 23.20 34.10 17.40 2.25
Net profit growth 21 48.60 23.10 18.80
Profitability ratios (%)        
OPM 20.60 17 14.50 13
EBIT margin 20.10 17.90 14.30 12.20
Net profit margin 14.70 13.30 9.60 7.81
RoCE 24.20 22.40 18.30 17.80
RoNW 4.52 4.79 4.16 4.22
RoA 4.41 4.15 3.07 2.85
Per share ratios ()        
EPS 31.10 25.70 17.30 14.10
Dividend per share 1.50 1.50 1.50 1.20
Cash EPS 27.30 22.10 14.30 11.30
Book value per share 188 157 112 96.20
Valuation ratios        
P/E 7.22 5.20 12.10 16.80
P/CEPS 8.22 6.07 14.80 20.90
P/B 1.20 0.85 1.88 2.45
EV/EBIDTA 4.70 3.37 8.09 10.60
Payout (%)        
Dividend payout -- 7.04 8.66 8.53
Tax payout (26) (23) (25) (25)
Liquidity ratios        
Debtor days 91.50 99.50 101 86.70
Inventory days 40.40 43.80 41.90 32.80
Creditor days (62) (58) (50) (39)
Leverage ratios        
Interest coverage (55) (34) (9.50) (6.60)
Net debt / equity -- -- 0.21 0.27
Net debt / op. profit (0.20) (0.10) 0.89 1.13
Cost breakup ()        
Material costs (47) (47) (53) (60)
Employee costs (14) (15) (14) (10)
Other costs (19) (21) (18) (16)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 424 386 361 360
yoy growth (%) 9.75 7.18 0.10 (10)
Raw materials (198) (183) (193) (218)
As % of sales 46.60 47.30 53.40 60.40
Employee costs (61) (59) (51) (38)
As % of sales 14.30 15.20 14.20 10.40
Other costs (79) (79) (65) (58)
As % of sales 18.50 20.50 17.90 16.20
Operating profit 87.20 65.50 52.30 46.80
OPM 20.60 17 14.50 13
Depreciation (7.60) (7.30) (6.10) (5.50)
Interest expense (1.60) (2) (5.40) (6.70)
Other income 5.66 11 5.45 2.73
Profit before tax 83.70 67.20 46.20 37.30
Taxes (21) (16) (12) (9.20)
Tax rate (26) (23) (25) (25)
Minorities and other -- -- -- --
Adj. profit 62.20 51.40 34.60 28.10
Exceptional items -- -- -- --
Net profit 62.20 51.40 34.60 28.10
yoy growth (%) 21 48.60 23.10 18.80
NPM 14.70 13.30 9.60 7.81
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 83.70 67.20 46.20 37.30
Depreciation (7.60) (7.30) (6.10) (5.50)
Tax paid (21) (16) (12) (9.20)
Working capital 69.60 84.50 93.30 65.10
Other operating items -- -- -- --
Operating cashflow 124 129 122 87.70
Capital expenditure 115 97.60 48.80 25.90
Free cash flow 239 226 171 114
Equity raised 357 313 249 233
Investments 80.80 33.90 10.70 9.92
Debt financing/disposal (39) (47) 14.20 18.60
Dividends paid -- 3 3 2.40
Other items -- -- -- --
Net in cash 638 529 448 377
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 20 20 20 20
Preference capital -- -- -- --
Reserves 355 293 249 204
Net worth 375 313 269 224
Minority interest
Debt 0.52 5.07 33.60 61.30
Deferred tax liabilities (net) 5.69 5.43 5.86 9.82
Total liabilities 382 324 309 296
Fixed assets 122 123 123 117
Intangible assets
Investments 80.80 34.30 18.20 11.10
Deferred tax asset (net) -- -- 0.28 2.63
Net working capital 166 152 160 151
Inventories 46.60 47.40 36.20 45.40
Inventory Days 40.10 44.80 -- 46
Sundry debtors 111 101 122 109
Debtor days 95.80 95.70 -- 111
Other current assets 85.30 69 58.60 49.90
Sundry creditors (60) (55) (48) (47)
Creditor days 52 51.70 -- 47.30
Other current liabilities (17) (11) (9) (7.40)
Cash 13.80 14.60 7.58 14.60
Total assets 382 324 309 296
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Dec-2021 Sep-2021 Jun-2021 Mar-2021 Dec-2020
Gross Sales 120 127 122 79.60 115
Excise Duty -- -- -- -- --
Net Sales 120 127 122 79.60 115
Other Operating Income -- -- -- -- --
Other Income 2.64 3.46 2.01 2.53 0.73
Total Income 123 131 124 82.10 115
Total Expenditure ** 96.40 98.20 96.90 64.30 94.80
PBIDT 26.10 32.70 27.30 17.80 20.70
Interest 0.31 0.20 0.38 0.57 0.39
PBDT 25.80 32.50 27 17.20 20.30
Depreciation 2.18 1.99 1.92 1.89 1.90
Minority Interest Before NP -- -- -- -- --
Tax 5.75 7.75 7.17 3.09 4.80
Deferred Tax 0.25 (0.30) 0.16 (0.40) 0.16
Reported Profit After Tax 17.60 23 17.70 12.60 13.50
Minority Interest After NP -- -- -- 0.01 --
Net Profit after Minority Interest 17.60 23 17.70 12.60 13.50
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item 17.60 23 17.70 12.60 13.50
EPS (Unit Curr.) 8.79 11.50 8.85 6.29 6.73
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 20 20 20 20 20
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 21.80 25.70 22.40 22.30 18.10
PBDTM(%) 21.50 25.50 22.10 21.60 17.70
PATM(%) 14.70 18.10 14.50 15.80 11.70
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity